Trial Profile
A Single-Dose, Four-Period, Four-Treatment, Four-Way Crossover Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Mar 2017
Price :
$35
*
At a glance
- Drugs Promethazine/hydrocodone/paracetamol (Primary) ; Hydrocodone/ibuprofen; Tramadol/paracetamol
- Indications Acute pain; Nausea and vomiting
- Focus Pharmacokinetics
- Sponsors Charleston Laboratories
- 12 Jun 2015 New trial record